Description
The aim of this study is to demonstrate safety and efficacy of autologous bioengineered skin incorporating (1) NovoSorb® polyurethane polymer or (2) platelet-derived hydrogel in closing full thickness wounds in a porcine wound model.
This pilot study is scheduled to take place in 2022-2023 and precedes a human clinical trial due to begin 2023.
Please contact us to initiate discussions 4-6 months prior to planned start date of research. This project is most suitable for those interested in a career in burn surgery or plastic & reconstructive surgery.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
human skin equivalent; bioengineered skin; tissue engineering; burns; full thickness wounds
School
Central Clinical School » Surgery - Alfred
Available options
PhD/Doctorate
Masters by research
Honours
BMedSc(Hons)
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
Alfred Hospital